AOD 9604 5mg

DRAGON PHARMA AOD 9604

AOD 9604 is a highly specialized peptide derived from the human growth hormone (HGH) fragment 177-191, designed to stimulate fat burning and prevent new fat formation without the side effects associated with full HGH. Manufactured by Dragon Pharma, each vial contains 5 mg of AOD 9604 and is formulated to help athletes and bodybuilders reduce body fat, enhance fat metabolism, and achieve a leaner physique. Its fat-loss properties make it an ideal choice for those looking to optimize their cutting cycles or maintain lean muscle during training.

DRUG COMPOSITION

Active substance: AOD 9604 (5 mg per vial)
Excipients: Stabilizers and sterile water for injection.

PHARMACEUTICAL FORM

AOD 9604 is supplied as a lyophilized powder that must be reconstituted with bacteriostatic water for subcutaneous injection.

PHARMACEUTICAL GROUP AND ATC CODE

Pharmaceutical Group: Peptide hormone fragment (lipolytic agent)
ATC Code: Not officially classified under ATC for this fragment.

PHARMACOLOGICAL PROPERTIES

AOD 9604 is a lipolytic agent that mimics the fat-burning effects of human growth hormone without increasing blood sugar levels or causing muscle growth. It activates lipolysis (fat breakdown) and inhibits lipogenesis (the formation of fat), leading to more effective fat loss. AOD 9604 has no effect on muscle development, making it ideal for bodybuilders looking to cut fat while preserving lean muscle.

PROFILE

• Chemical name: Modified Human Growth Hormone Fragment 177-191
• Chemical formula: C78H123N23O23S2
• Percentage of anabolic activity: None
• Percentage of androgenic activity: None
• Active half life: ~4 hours
• Recommended dosage: 200-300 mcg daily, injected subcutaneously
• Acne: Unlikely
• Bloating (water retention): None
• HBR: Unlikely
• Hepatic toxicity: None
• Aromatization: None

THERAPEUTICAL INDICATIONS

AOD 9604 is indicated for athletes and bodybuilders aiming to:

• Enhance fat loss during cutting cycles.
• Reduce body fat while maintaining lean muscle mass.
• Optimize metabolism and fat utilization without adverse hormonal effects.
  It can also be used in general weight management programs for individuals looking to improve body composition.

DOSES AND METHOD OF ADMINISTRATION

The recommended dosage for AOD 9604 is 200-300 mcg per day, administered subcutaneously. For optimal fat-loss effects, it is typically injected daily for a cycle of 8-12 weeks. Dosage and length of cycle can be adjusted based on individual goals and body fat reduction targets.

CYCLE/STACKING

AOD 9604 can be stacked with other peptides or performance-enhancing compounds to maximize fat loss and preserve muscle. Here are some example cycles:

• Cutting Cycle (8-12 weeks):

  • AOD 9604: 300 mcg daily
  • Stack with Clenbuterol for enhanced fat-burning effects.
  • Combine with Anavar to maintain lean muscle while cutting fat.

• Recomposition Cycle (8-12 weeks):

  • AOD 9604: 250 mcg daily
  • Stack with Winstrol (Stanozolol) to achieve a lean, defined physique.

POST CYCLE THERAPY

AOD 9604 does not affect natural hormone levels or testosterone production, so post-cycle therapy (PCT) is not required. It can be safely used without impacting endocrine function.

SIDE EFFECTS

AOD 9604 is well-tolerated, but mild side effects such as redness or irritation at the injection site, nausea, or headaches may occur. These effects are usually temporary and subside on their own. If severe side effects occur, discontinue use and consult a healthcare provider.

CONTRAINDICATIONS

AOD 9604 should not be used by individuals with a known hypersensitivity to peptides. Pregnant or breastfeeding women should avoid its use. Always consult with a healthcare provider before beginning any new peptide therapy.

OVERDOSE

Overdosing on AOD 9604 is rare, but excessive doses may cause increased fatigue or dizziness. If overdose symptoms are experienced, discontinue use and seek medical advice.

WARNINGS AND SPECIAL PRECAUTIONS FOR USE:

AOD 9604 should be used responsibly, particularly in combination with other fat-loss agents. It is important to follow proper dosing guidelines and consult a healthcare provider if there are any underlying health concerns.

INTERACTIONS WITH OTHER DRUGS

There are no known drug interactions with AOD 9604, but it is advisable to consult a healthcare professional if using other performance-enhancing drugs or supplements.

PRESENTATION, PACKAGING

AOD 9604 by Dragon Pharma is available in 2 mL vials containing 5 mg of lyophilized peptide. The product is packaged securely to maintain its integrity during shipment.

STORAGE

Store AOD 9604 in a cool, dry place away from direct sunlight. Once reconstituted, keep the solution refrigerated and use within 30 days. Keep out of reach of children.

DELIVERY TO THE USA

We offer fast and discreet delivery of Dragon Pharma AOD 9604 to the USA. All orders are carefully packaged to ensure privacy and product safety during transit.

LEGAL STATUS

AOD 9604 is available for research purposes and off-label use in many countries, including the USA. It is not FDA-approved for fat-loss or bodybuilding purposes, so be sure to check your local regulations before purchasing.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

Dragon Pharma
Europe

EXTERNAL LINKS

• AOD 9604 Wiki, wikipedia.org
• IGF-1 LR3 National Institutes of Health, pubmed.ncbi.nlm.nih.gov